DOI=10.1007/BF01753729
Jacubovich R., Dore J.-F.
Tumour-associated antigens in culture medium of malignant melanoma cell strains.
Cancer Immunol. Immunother. 7:59-64(1979)

PubMed=3882112; DOI=10.1038/bjc.1985.45; PMCID=PMC1976943
Jacubovich R., Cabrillat H., Gerlier D., Bailly M., Dore J.-F.
Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism.
Br. J. Cancer 51:335-345(1985)

DOI=10.1159/000417159
Bailly M., Bertrand S., Dore J.-F.
Experimental model of human tumor spontaneous metastasis in immunosupressed newborn rat.
(In book chapter) Immune-deficient animals in experimental medicine; Wu B.-Q., Zheng J. (eds.); pp.140-146; Karger; Basel; Switzerland (1989)

PubMed=8012932; DOI=10.1016/0304-3835(94)90197-x
Mey A., Berthier-Vergnes O., Apoil P.A., Dore J.-F., Revillard J.-P.
Expression of the galactose binding protein Mac-2 by human melanoma cell-lines.
Cancer Lett. 81:155-163(1994)

PubMed=8125107; DOI=10.1111/j.1432-1033.1994.tb18647.x
Boukerche H., Benchaibi M., Berthier-Vergnes O., Lizard G., Bailly M., Bailly M., McGregor J.L.
Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
Eur. J. Biochem. 220:485-491(1994)